ImmunityBio, Inc. IBRX
At closeNov 11, 2026, 7:48 PM EST
After hours · Nov 11, 7:48 PM ET
- YTD
- +236.87%
- 1 year
- +211.68%
Discussion (3500)
Sign in to join the discussion
If we had real news, investigational news doing real stories. They would interview and research and ask the question why isn't Anktiva approved for multiple uses in America and Europe.
Paul Silberberg your thoughts please. Yours are the only ones I respect on this board.
I would think this news would be good for a $1-$2 pop minimum, but once again there will be ZERO 000000 MSM coverage from the corrupt media puppets of BIG PHARMA ad $$$$ and Wall Street.....
If the media cared they would cover ImmunityBio fairly and be pressuring the FDA and exposing them and demand to expand use and save lives. The media in America and the world is 100% $$$$$$$$$ drive.
Mike
holding into earnings really. How about hold for $25-$200-$300 a share
FDA and EMA are both the same, corrupt and support big Pharma over patients and lives. The world is a sick money worshipping, power seeking evil planet. Money is the root of all evil.
FDA and EMA should both approve Anktiva for all bladder cancer and lung and pancreatic and and and but no it's the FDA and EMA to the rescue preserving the $$$$ for Big EVIL Pharma and their no cure treatment repeat businesses.
Daredevil 👿 go 🖕yourself better yet 👉👿
CNBC app shows no news for UAE approval. CNBC FoxB are puppets of wall street and big pharma. More evidence of corruption in America and the world.
Saudi and now UAE means millions have access plus when the news is out thousands of wealthy people will travel there for treatment.
Sad thing is the FDA and European regulators drag their feet protecting Merck and Keytruda and others and let people die.
Pam
Good post. If the story hasn't changed keep holding for the ride higher
So tired of this slow down trend.... WHY???
There is no reason for it.
